These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26930048)

  • 21. Involvement of gamma interferon inducible lysosomal thiol reductase in the innate immune responses of red swamp crayfish, Procambarus clarkii.
    Liu M; Liu L; Abbas MN; Kausar S; Zhang JW; Ye ZZ; Qian XY; Zhao XM; Chu SH; Dai LS
    Dev Comp Immunol; 2019 Oct; 99():103405. PubMed ID: 31145913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization and expression analysis of interferon-gamma-inducible lysosomal thiol reductase (GILT) gene from pearl oyster Pinctada fucata.
    Zhang D; Pan D; Cui S; Su T; Qiu L; Zhu C; Jiang S
    Dev Comp Immunol; 2010 Sep; 34(9):969-76. PubMed ID: 20444427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT.
    Rausch MP; Hastings KT
    Mol Immunol; 2015 Dec; 68(2 Pt A):124-8. PubMed ID: 26116226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trichinella spiralis: Knockdown of gamma interferon inducible lysosomal thiol reductase (GILT) results in the reduction of worm burden.
    Fei H; Naqvi MA; Naqvi SZ; Xu L; Song X; Li X; Yan R
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009958. PubMed ID: 34847145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular structure and functional characterization of the gamma-interferon-inducible lysosomal thiol reductase (GILT) gene in largemouth bass (Microptenus salmoides).
    Yang Q; Zhang J; Hu L; Lu J; Sang M; Zhang S
    Fish Shellfish Immunol; 2015 Dec; 47(2):689-96. PubMed ID: 26477576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing.
    Hastings KT; Lackman RL; Cresswell P
    J Immunol; 2006 Dec; 177(12):8569-77. PubMed ID: 17142755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
    Mudaliar K; Tetzlaff MT; Duvic M; Ciurea A; Hymes S; Milton DR; Tsai KY; Prieto VG; Torres-Cabala CA; Curry JL
    Hum Pathol; 2016 Apr; 50():79-89. PubMed ID: 26997441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions.
    Singh RS; Diwan AH; Zhang PS; Prieto VG
    J Cutan Pathol; 2007 Mar; 34(3):220-5. PubMed ID: 17302605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of gamma-interferon-inducible lysosomal thiol reductase (GILT) is associated with poor disease-free survival in breast cancer patients.
    Xiang YJ; Guo MM; Zhou CJ; Liu L; Han B; Kong LY; Gao ZC; Ma ZB; Wang L; Feng M; Chen HY; Jia GT; Gao DZ; Zhang Q; Li L; Li YY; Yu ZG
    PLoS One; 2014; 9(10):e109449. PubMed ID: 25333930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
    D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
    Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure of the promonocytic cell line THP-1 to Escherichia coli induces IFN-gamma-inducible lysosomal thiol reductase expression by inflammatory cytokines.
    Lackman RL; Cresswell P
    J Immunol; 2006 Oct; 177(7):4833-40. PubMed ID: 16982925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.
    Massi D; De Nisi MC; Franchi A; Mourmouras V; Baroni G; Panelos J; Santucci M; Miracco C
    Mod Pathol; 2009 Jan; 22(1):21-30. PubMed ID: 18660796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GILT: Shaping the MHC Class II-Restricted Peptidome and CD4(+) T Cell-Mediated Immunity.
    Hastings KT
    Front Immunol; 2013 Dec; 4():429. PubMed ID: 24409178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.
    Brożyna AA; Jóźwicki W; Janjetovic Z; Slominski AT
    Hum Pathol; 2013 Mar; 44(3):374-87. PubMed ID: 22995334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of gamma-interferon-inducible lysosomal thiol reductase (GILT) homologues in the fruit fly Drosophila melanogaster.
    Kongton K; McCall K; Phongdara A
    Dev Comp Immunol; 2014 Jun; 44(2):389-96. PubMed ID: 24491521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
    Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E
    Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.